Portman Square Capital LLP Dexcom Inc Transaction History

Portman Square Capital LLP

  • $2.47 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024
SELL
$75.49 - $124.16 $3.45 Million - $5.67 Million
-45,659 Reduced 86.73%
6,988 $867,000
Q3 2023

Oct 30, 2023
BUY
$86.06 - $137.93 $4.29 Million - $6.88 Million
49,905 Added 1820.02%
52,647 $4.91 Million
Q2 2023

Jul 26, 2023
BUY
$112.47 - $130.98 $308,392 - $359,147
2,742 New
2,742 $352,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email